Restech
  • Home
  • Our solutions
    • First
    • Resmon Pro
    • Resolve
  • Company
  • About Oscillometry
  • Contacts
Select Page
First
Resmon Pro

First

Resmon Pro

Resolve

About Oscillometry

Company

via Melchiorre Gioia, 63/61
20124 Milano Italy
T: (+39) 02.36.59.36.90
F: (+39) 02.36.59.36.92

REA: MI-1936811| Share Capital: € 10.000 i.v.| RESTECH P.IVA/CF: 07116980967 – privacy policy

  • Follow

The first mini-oscillometer, a revolution in pulmonary diagnostics.

First is a novel, revolutionary unique medical device for easy, fast, reliable measurements of respiratory function at normal tidal breathing, all in a compact stand-alone handheld device. First utilizes the proven and validated method of OSCILLOMETRY or FOT (forced oscillatory technique) to detect and localize peripheral and central obstructions, as well as tidal Expiratory Flow Limitation (EFLt).

Discover more
SUGGESTED READINGS

*1Kaminsky, D. A., et al. (2022). Clinical significance and applications of oscillometry. European Respiratory Review, 31(163), 1–19
*1Downie, S. R. et al(2013). Journal of Applied Physiology (Bethesda, Md. : 1985), 114(6), 770–777.
*2Dellacà, R. L. et al. (2004). The European Respiratory *Journal, 23(2), 232–240.
*3Dellacà, R. L. et al (2009). Intensive Care Medicine, 35(12), 2164–2172.
*4Milne, S. et al (2019). Journal of Applied Physiology (Bethesda, Md. : 1985), 126(5),1223–1231

 

SCIENTIFIC PAPERS

1. Walker PP, Pompilio PP, Zanaboni P, et al. Telemonitoring in Chronic Obstructive Pulmonary Disease (CHROMED). A Randomized Clinical Trial. Am J Respir Crit Care Med. 2018;198(5):620-628. doi:10.1164/rccm.201712-2404OC

2. Gobbi A, Milesi I, Govoni L, Pedotti A, Dellacà RL. A New Telemedicine System for the Home Monitoring of Lung Function in Patients with Obstructive Respiratory Diseases. 2009 Int Conf eHealth, Telemedicine, Soc Med. February 2009:117-122. doi:10.1109/eTELEMED.2009.18

3. Zimmermann SC, Huvanandana J, Nguyen CD, et al. Day-to-day variability of forced oscillatory mechanics for early detection of acute exacerbations in COPD. Eur Respir J. 2020;56(3). doi:10.1183/13993003.01739-2019

4. Gobbi A, Gulotta C, Suki B, et al. Monitoring of respiratory resistance in the diagnosis of mild-intermittent asthma. Clin Exp Allergy. 2019:0-1. doi:10.1111/cea.13376

5. Gobbi A, Dellacá RL, King G, Thamrin C. Toward Predicting Individual Risk in Asthma Using Daily Home Monitoring of Resistance. Am J Respir Crit Care Med. 2017;195(2):265-267. doi:10.1164/rccm.201603-0537LE